Delivery Order SPE2DB20D2104-SPE2DB22FS16X
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a prescription medication used to manage diabetes. The contract, valued at $1,963.28, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $16,755.44 for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen, a major...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order issued by the Defense Logistics Agency (DLA) worth $1,694.66. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a prescription medication used to treat type 2 diabetes. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,081.92 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,944.61 Firm Fixed Price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The award has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) with a ceiling value of $7,136.60. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used for the treatment of diabetes. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.50 delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used for diabetes management. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The specific delivery order, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,741.68 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat diabetes. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,153.55. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is responsible for providing medical supplies to the U.S. military and other federal agencies. The contract has an ultimate completion date of October 24, 2023 and is a firm...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS16XDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a prescription medication used to treat diabetes. The $15,125.88 firm fixed-price delivery order was placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award was made without any set-aside designations, indicating open competition. Amerisourcebergen's extensive pharmaceutical distribution capabilities and experience in servicing federal healthcare agencies have positioned the company as a key vendor for the DLA and other government customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 3/23/22 |